Literature DB >> 20843300

A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture.

Timothy J Underwood1, Mathieu F Derouet, Michael J White, Fergus Noble, Karwan A Moutasim, Eric Smith, Paul A Drew, Gareth J Thomas, John N Primrose, Jeremy P Blaydes.   

Abstract

BACKGROUND INFORMATION: Carcinoma of the oesophagus is the sixth leading cause of cancer death in the western world and is associated with a 5-year survival of less than 15%. Recent evidence suggests that stromal-epithelial interactions are fundamental in carcinogenesis. The advent of co-culture techniques permits the investigation of cross-talk between the stroma and epithelium in a physiological setting. We have characterized a histologically representative oesophageal organotypic model and have used it to compare the most commonly used squamous oesophageal cell line, HET-1A, with primary oesophageal squamous cells for use in studies of the oesophageal epithelium in vitro.
RESULTS: When grown in an organotypic culture with normal fibroblasts, the oesophageal carcinoma cell lines OE21 (squamous) and OE19 (adenocarcinoma) morphologically resembled the tumour of origin with evidence of stromal invasion and mucus production, respectively. However, HET-1A cells, which were derived from normal squamous oesophageal cells, appeared dysplastic and failed to display evidence of squamous differentiation. By comparison with primary oesophageal epithelial cells, the HET-1A cells were highly proliferative and did not express the epithelial markers E-cadherin or CK5/6 (casein kinase 5/6), or the stratified epithelial marker ΔNp63, but did express the mesenchymal markers vimentin and N-cadherin.
CONCLUSION: Studies of epithelial carcinogenesis will benefit from culture systems which allow manipulation of the stromal and epithelial layers independently. We have developed an organotypic culture using primary oesophageal squamous cells and fibroblasts in which a stratified epithelium with a proliferative basal layer that stains strongly for ΔNp63 develops. This model will be suitable for the study of the molecular events in the development of Barrett's oesophagus. The most commonly used normal oesophageal squamous cell line, HET-1A, does not have the characteristics of normal oesophageal squamous cells and should not be used in models of the normal oesophageal epithelium. Until more representative cell lines are available, future studies in oesophageal cancer will be reliant on the availability and manipulation of primary tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843300     DOI: 10.1042/BC20100071

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  17 in total

Review 1.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

2.  Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model.

Authors:  Nicola H Green; Bernard M Corfe; Jonathan P Bury; Sheila MacNeil
Journal:  J Vis Exp       Date:  2015-05-18       Impact factor: 1.355

3.  Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts.

Authors:  Benjamin P Sharpe; Annette Hayden; Antigoni Manousopoulou; Andrew Cowie; Robert C Walker; Jack Harrington; Fereshteh Izadi; Stella P Breininger; Jane Gibson; Oliver Pickering; Eleanor Jaynes; Ewan Kyle; John H Saunders; Simon L Parsons; Alison A Ritchie; Philip A Clarke; Pamela Collier; Nigel P Mongan; David O Bates; Kiren Yacqub-Usman; Spiros D Garbis; Zoë Walters; Matthew Rose-Zerilli; Anna M Grabowska; Timothy J Underwood
Journal:  Cell Rep Med       Date:  2022-06-21

4.  Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells.

Authors:  Christiane D Fichter; Corinna Herz; Claudia Münch; Oliver G Opitz; Martin Werner; Silke Lassmann
Journal:  BMC Cell Biol       Date:  2011-04-06       Impact factor: 4.241

5.  IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.

Authors:  E Smith; A R Ruszkiewicz; G G Jamieson; P A Drew
Journal:  Br J Cancer       Date:  2013-12-19       Impact factor: 7.640

6.  The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.

Authors:  Shin Saito; Kazue Morishima; Takashi Ui; Hiroko Hoshino; Daisuke Matsubara; Shumpei Ishikawa; Hiroyuki Aburatani; Masashi Fukayama; Yoshinori Hosoya; Naohiro Sata; Alan K Lefor; Yoshikazu Yasuda; Toshiro Niki
Journal:  BMC Cancer       Date:  2015-02-25       Impact factor: 4.430

7.  Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.

Authors:  Timothy J Underwood; Annette L Hayden; Mathieu Derouet; Edwin Garcia; Fergus Noble; Michael J White; Steve Thirdborough; Abbie Mead; Nicholas Clemons; Massimiliano Mellone; Chudy Uzoho; John N Primrose; Jeremy P Blaydes; Gareth J Thomas
Journal:  J Pathol       Date:  2015-02       Impact factor: 7.996

8.  Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.

Authors:  Edwin Garcia; Annette Hayden; Charles Birts; Edward Britton; Andrew Cowie; Karen Pickard; Massimiliano Mellone; Clarisa Choh; Mathieu Derouet; Patrick Duriez; Fergus Noble; Michael J White; John N Primrose; Jonathan C Strefford; Matthew Rose-Zerilli; Gareth J Thomas; Yeng Ang; Andrew D Sharrocks; Rebecca C Fitzgerald; Timothy J Underwood
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

9.  Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate.

Authors:  Mohammed Adil Butt; Hayley Pye; Rehan J Haidry; Dahmane Oukrif; Saif-U-Rehman Khan; Ignazio Puccio; Michael Gandy; Halla W Reinert; Ellie Bloom; Mohammed Rashid; Gokhan Yahioglu; Mahendra P Deonarain; Rifat Hamoudi; Manuel Rodriguez-Justo; Marco R Novelli; Laurence B Lovat
Journal:  Oncotarget       Date:  2017-04-11

10.  The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells.

Authors:  J Dinesh Kumar; Sandhir Kandola; Laszlo Tiszlavicz; Zita Reisz; Graham J Dockray; Andrea Varro
Journal:  Br J Cancer       Date:  2016-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.